VAMP3 (Cellubrevin) Protein
Overview VAMP3 (Vesicle-Associated Membrane Protein 3), also known as Cellubrevin , is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family of proteins. VAMP3 functions as a v-SNARE (vesicular SNARE) protein that mediates vesicle fusion with target membranes during intracellular trafficking, synaptic vesicle release, and endosomal recycling. [@jahn_sudhof2006]
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">VAMP3 Protein</th></tr> <tr><td><strong>Protein Name</strong></td><td>VAMP3 (Cellubrevin)</td></tr> <tr><td><strong>Gene Symbol</strong></td><td>VAMP3</td></tr> <tr><td><strong>Gene</strong></td><td>[VAMP3 Gene](/genes/vamp3)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[Q15886](https://www.uniprot.org/uniprot/Q15886)</td></tr> <tr><td><strong>Protein Family</strong></td><td>SNARE family, VAMP subfamily</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>11.5 kDa (100 amino acids)</td></tr> <tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicles, endosomes, plasma membrane</td></tr> <tr><td><strong>Expression</strong></td><td>Ubiquitous; high in brain, endocrine cells</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">4 edges</a></td> </tr> </table> </div>
Structure
Domain Architecture VAMP3 contains the characteristic SNARE domain structure:
...
VAMP3 (Cellubrevin) Protein
Overview VAMP3 (Vesicle-Associated Membrane Protein 3), also known as Cellubrevin , is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family of proteins. VAMP3 functions as a v-SNARE (vesicular SNARE) protein that mediates vesicle fusion with target membranes during intracellular trafficking, synaptic vesicle release, and endosomal recycling. [@jahn_sudhof2006]
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">VAMP3 Protein</th></tr> <tr><td><strong>Protein Name</strong></td><td>VAMP3 (Cellubrevin)</td></tr> <tr><td><strong>Gene Symbol</strong></td><td>VAMP3</td></tr> <tr><td><strong>Gene</strong></td><td>[VAMP3 Gene](/genes/vamp3)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[Q15886](https://www.uniprot.org/uniprot/Q15886)</td></tr> <tr><td><strong>Protein Family</strong></td><td>SNARE family, VAMP subfamily</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>11.5 kDa (100 amino acids)</td></tr> <tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicles, endosomes, plasma membrane</td></tr> <tr><td><strong>Expression</strong></td><td>Ubiquitous; high in brain, endocrine cells</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">4 edges</a></td> </tr> </table> </div>
Structure
Domain Architecture VAMP3 contains the characteristic SNARE domain structure:
| Region | Position | Function | |--------|-----------|----------| | N-terminal regulatory region | 1-25 aa | Hypervariable N-terminus; regulation of SNARE complex assembly | | SNARE motif (central) | 26-72 aa | Formation of the coiled-coil SNARE complex | | Transmembrane anchor | 73-100 aa | C-terminal transmembrane helix; membrane anchoring |
The SNARE motif consists of 16-18 heptad repeats that form a highly stable four-helix bundle when complexed with other SNARE proteins.
During vesicle fusion, VAMP3 (v-SNARE) pairs with target membrane SNAREs (t-SNAREs) to form the SNARE complex:
v-SNARE : VAMP3 on the vesicle membrane
t-SNAREs : SNAP25/SNAP23 and Syntaxin on the target membrane
Complex : Four-helix bundle (1 VAMP3 + 1 Syntaxin + 1-2 SNAP25)
The formation of this highly stable complex drives membrane fusion through the release of free energy. [@rizi_snare2018]
Normal Function
Synaptic Vesicle Trafficking VAMP3 plays essential roles in neurotransmitter release: [@kelley_snare2022]
Vesicle docking : VAMP3 on synaptic vesicles interacts with presynaptic membrane t-SNAREs
SNARE complex assembly : Formation of the ternary SNARE complex (VAMP3-SNAP25-Syntaxin)
Membrane fusion : Zippering of the SNARE complex pulls membranes together
Neurotransmitter release : Fusion pore opening releases neurotransmitter into the synaptic cleft
Vesicle recycling : VAMP3 is recycled for another round of fusion
Endosomal Recycling Beyond synaptic function, VAMP3 participates in: [@kranes2019]
Endosome trafficking : Sorting and recycling of endosomal vesicles
Membrane protein recycling : Receptor and transporter recycling
Autophagy : SNARE-mediated membrane fusion events in autophagy
Lysosomal delivery : Endosome-lysosome fusion
Cellular Functions
Constitutive exocytosis : Non-synaptic vesicle fusion pathways
Cellular homeostasis : Membrane trafficking and protein localization
Signal transduction : Receptor recycling and signaling termination
Role in Neurodegenerative Diseases
Alzheimer's Disease SNARE dysfunction is a key feature of Alzheimer's disease: [@selkoe_synaptic2002]
Synaptic Failure in AD
SNARE complex disruption : Reduced SNARE complex formation in AD brains
VAMP3 downregulation : Decreased VAMP3 expression in hippocampus and cortex
Synaptic vesicle depletion : Impaired vesicle recycling and reduced releasable pool
Calcium dysregulation : Altered SNARE function due to calcium homeostasis disruption
Mechanisms
Aβ toxicity : Amyloid-β oligomers directly impair SNARE complex assembly
Tau pathology : Hyperphosphorylated tau disrupts presynaptic function
Oxidative stress : ROS damages SNARE proteins and impairs function
Energy failure : Reduced ATP impairs SNARE cycling and vesicle replenishment
Evidence
Post-mortem studies show reduced VAMP3 in AD temporal cortex
Mouse models of AD exhibit impaired VAMP3-dependent vesicle trafficking
Aβ directly binds to and disrupts SNAP25-VAMP3 interactions
Parkinson's Disease Synaptic dysfunction is increasingly recognized in PD:
Synaptic vesicle deficits : Impaired vesicle cycling in dopaminergic neurons
SNARE alterations : Changes in SNARE protein expression and function
α-Synuclein interaction : α-Synuclein can affect SNARE-mediated trafficking
Exocytosis defects : Impaired neurotransmitter release in PD models
Amyotrophic Lateral Sclerosis
Motor neuron dysfunction : SNARE deficits in ALS motor neurons
Synaptic instability : Impaired vesicle cycling and synaptic maintenance
Calcium dysregulation : SNARE sensitivity to calcium alterations
Huntington's Disease
Vesicular transport : Impaired synaptic vesicle function in striatal neurons
SNARE regulation : Dysregulated SNARE protein expression
Energy deficits : Mitochondrial dysfunction affecting SNARE function
Protein Interactions VAMP3 interacts with multiple SNARE and regulatory proteins:
| Interactor | Interaction Type | Functional Relevance | |------------|-----------------|---------------------| | SNAP25 | SNARE complex | Synaptic vesicle fusion | | SNAP23 | SNARE complex | Non-synaptic fusion | | Syntaxin 1/4 | SNARE complex | Target membrane t-SNARE | | Munc18 | Regulatory | Syntaxin chaperone, fusion regulation | | Munc13 | Regulatory | Active zone organization | | Synaptotagmin | Calcium sensor | Calcium-triggered release | | α-Synuclein | Binding | Potential regulatory interaction | | Vti1A | Alternate SNARE | Endosomal SNARE complex |
Regulation
Calcium Regulation
Synaptotagmin family proteins sense calcium and regulate VAMP3-mediated fusion
Calcium influx triggers rapid vesicle release
Phosphorylation
Casein kinase can phosphorylate VAMP3, regulating SNARE complex dynamics
Kinase pathways modulate vesicle trafficking
Lipid Environment
Membrane lipid composition affects SNARE function
Cholesterol and phosphoinositides regulate VAMP3 activity
Therapeutic Implications Targeting SNARE dysfunction represents a therapeutic strategy for neurodegenerative diseases: [@vanthe_neurons2018]
Challenges
Complex regulation : SNARE function is highly regulated and context-dependent
BBB penetration : Many therapeutic agents don't cross the blood-brain barrier
System specificity : CNS-targeted delivery is challenging
Approaches
SNARE stabilizers : Compounds that enhance SNARE complex stability
Gene therapy : Viral vectors for SNARE protein expression
Calcium modulators : Targeting upstream calcium signaling
Synaptic protection : Neuroprotective strategies to preserve synaptic function
Antibodies : VAMP3-specific antibodies for detection and localization
Botulinum toxins : Proteases that cleave SNARE proteins for functional studies
Fluorescent tagging : GFP-RFP fusions for live imaging of vesicle dynamics
siRNA/shRNA : Knockdown constructs for loss-of-function studies
Summary VAMP3 (Cellubrevin) is a v-SNARE protein essential for synaptic vesicle trafficking and neurotransmitter release. In Alzheimer's disease, VAMP3 dysfunction contributes to synaptic failure, one of the earliest and most critical pathological features. Similarly, in Parkinson's disease and other neurodegenerative conditions, impaired SNARE-mediated vesicle trafficking represents a key mechanism of synaptic dysfunction. Understanding VAMP3 and SNARE biology provides insight into therapeutic strategies targeting synaptic protection and restoration.
See Also
[VAMP3 Gene](/genes/vamp3)
[SNARE Complex](/mechanisms/snare-complex)
[Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Synaptic Vesicles](/cell-types/presynaptic-terminals)
[Neurotransmission](/mechanisms/neurotransmission)
References
[Jahn & Scheller, VAMP proteins - from vesicular fusion to synaptic transmission (2006)](https://doi.org/10.1038/nrn1957)
[Südhof TC, Neurotransmitter release: functional and molecular organization of the synapse (2023)](https://doi.org/10.1101/cshperspect.a035816)
[Selkoe DJ, Alzheimer's disease is a synaptic failure (2002)](https://doi.org/10.1126/science.1074069)
[Vandrovcova et al., SNARE complex dysfunction in neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/28455951/)
[Rizo & Rosen, Molecular mechanisms underlying synaptic function (2018)](https://doi.org/10.1038/nrn.2018.9)
[Shen et al., Synaptic vesicle proteins and neuronal function in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31740584/)
[Kelley & Chapman, Synaptic vesicle trafficking in health and disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35648574/)
[Krans & Mühlschlegel, VAMP3 in membrane trafficking and synaptic function (2019)](https://pubmed.ncbi.nlm.nih.gov/31139202/)
Show full description